Topic: power morcellators
2014 Fierce 15 company Gynesonics unveiled data spanning more than five years, tracking its ablation treatment for uterine fibroids.
After logging a whopping 42% sales growth in 2015 thanks to the $50 billion merger with Covidien, Medtronic saw just a 1% uptick in sales from 2015 to 2016.
Here's Monday's medtech news of note.
In 2015, the Government Accountability Office announced an investigation into power morcellators, bladed, drill-shaped devices used to remove uterine fibroids in minimally invasive procedures. Now, the results are in—and they’re not good.
After FDA inspections turned up “limited to no reporting” of injuries or deaths stemming from the use of medical devices at 17 hospitals, the agency is setting out to improve the way it works with hospitals on device data collection and reporting.